Ligand Pharmaceuticals (LGND)

AI Score

Unlock

102.84

-5.89 (-5.42%)

At close: Apr 03, 2025, 3:59 PM

101.70

-1.11%

Pre-market: Apr 04, 2025, 05:03 AM EDT

Ligand Pharmaceuticals Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002	FY 2001	FY 2000	FY 1999	FY 1998	FY 1997	FY 1996	FY 1995	FY 1994
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003	Dec 31, 2002	Dec 31, 2001	Dec 31, 2000	Dec 31, 1999	Dec 31, 1998	Dec 31, 1997	Dec 31, 1996	Dec 31, 1995	Dec 31, 1994
Revenue	167.13M	131.31M	196.25M	277.13M	186.42M	120.28M	251.45M	141.1M	108.97M	71.91M	64.54M	48.97M	31.39M	30.04M	23.54M	38.94M	27.32M	12.89M	140.96M	176.61M	163.51M	141.14M	96.64M	76.34M	48.11M	40.9M	17.7M	51.7M	36.8M	24.5M	13.3M
Cost of Revenue	11.07M	35.05M	52.83M	62.18M	30.42M	11.35M	6.34M	5.37M	5.57M	5.81M	9.14M	5.73M	3.6M	4.91M	n/a	15.23M	n/a	n/a	22.64M	39.85M	39.8M	31.62M	20.31M	13.95M	1.62M	3.1M	-7.7M	-9.8M	-9.4M	-3.7M	24.7M
Gross Profit	156.06M	96.27M	143.42M	214.96M	156M	108.94M	245.12M	135.74M	103.4M	66.11M	55.4M	43.24M	27.79M	25.13M	23.54M	23.7M	27.32M	12.89M	118.32M	136.76M	123.71M	109.52M	76.33M	62.39M	46.49M	37.8M	25.4M	61.5M	46.2M	28.2M	-11.4M
Operating Income	-22.61M	11.94M	-25.5M	78.89M	8.55M	-5.72M	163.73M	68.08M	43.88M	27.33M	19.63M	14.94M	574K	-698K	-29.3M	-9.97M	-97.28M	-60.17M	-168.77M	-26.47M	-37.37M	-19.18M	-24.15M	-23.14M	-45.88M	-56.3M	-69.6M	-30.8M	-32.9M	-24.9M	-20.9M
Interest Income	8.05M	7.71M	2.05M	886K	8.08M	28.43M	14M	n/a	n/a	n/a	n/a	n/a	381K	31K	440K	586K	2.16M	8.65M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	2.52M	63.66M	36.01M	47.3M	-10.54M	796.64M	173.33M	57.23M	7.96M	35.33M	11.3M	9.21M	-3.87M	-2.93M	-15.4M	-9.87M	-97.52M	-53.46M	-174.27M	36.34M	-44.91M	-37.46M	-32.6M	-31.5M	-46.71M	-62M	-112.6M	-92.1M	-29.2M	-58.7M	-26.4M
Net Income	-4.03M	52.15M	-5.22M	57.14M	-2.98M	629.3M	143.32M	12.56M	-1.64M	257.31M	12.02M	11.42M	-527K	10.18M	-12.52M	-1.95M	-98.11M	281.69M	-31.74M	-36.4M	-45.14M	-37.46M	-32.6M	-42.99M	-72.38M	-74.7M	-117.9M	-100.2M	-37.3M	-64.2M	-27.1M
Selling & General & Admin	78.65M	52.79M	70.06M	57.48M	64.44M	41.88M	37.73M	28.65M	26.62M	24.38M	22.57M	17.98M	16.11M	14.98M	29.72M	15.21M	23.79M	30.41M	248.28M	107.16M	95.88M	61.02M	41.68M	34.43M	34.11M	27.3M	16.6M	10.1M	10.2M	8M	7M
Research & Development	21.43M	24.54M	36.08M	69.01M	59.39M	55.91M	27.86M	26.89M	21.22M	13.38M	12.12M	9.27M	10.79M	10.29M	22.07M	39.87M	30.77M	44.62M	41.93M	56.08M	65.2M	67.68M	58.81M	51.1M	51.29M	59.4M	70.7M	72.4M	59.5M	41.4M	n/a
Other Expenses	78.59M	7M	34.24M	9.57M	23.44M	16.86M	15.79M	12.12M	10.64M	-10.03M	-3.19M	-2.14M	-2.79M	n/a	n/a	n/a	-1.96M	-1.96M	-3.12M	78.05M	62.03M	50.53M	16.69M	n/a	6.97M	7.4M	7.7M	9.8M	9.4M	3.7M	2.5M
Operating Expenses	178.66M	84.32M	140.38M	136.06M	147.27M	114.66M	81.39M	67.66M	58.48M	37.76M	34.69M	27.26M	26.9M	25.27M	51.79M	70.32M	52.59M	73.07M	287.09M	163.23M	161.08M	128.7M	100.48M	85.53M	92.37M	94.1M	95M	92.3M	79.1M	53.1M	9.5M
Interest Expense	3.04M	656K	1.8M	18.74M	27.42M	35.74M	48.28M	11.4M	12.18M	11.8M	4.86M	2.08M	3.31M	2.51M	58K	270K	202K	735K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-15.23M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	189.74M	119.37M	193.21M	198.24M	177.69M	126M	87.73M	73.03M	64.06M	43.56M	43.83M	32.99M	30.5M	30.18M	51.79M	70.32M	52.59M	73.07M	309.73M	203.08M	200.88M	160.32M	120.79M	99.48M	93.99M	97.2M	87.3M	82.5M	69.7M	49.4M	34.2M
Income Tax Expense	-6.55M	9.84M	41.23M	-10.29M	-7.55M	167.34M	30.01M	44.67M	10.33M	-219.6M	410K	374K	-1.19M	-13.1M	-2.62M	-7.92M	-55K	-18.7M	-38.41M	59K	233K	18.28M	8.45M	19.86M	26.49M	18.4M	48.3M	69.4M	4.4M	39.3M	6.2M
Shares Outstanding (Basic)	18.29M	17.3M	16.87M	16.63M	16.18M	19M	24.05M	21.03M	20.83M	19.79M	20.42M	20.31M	19.1M	19.66M	19.61M	18.86M	15.92M	16.35M	13.44M	12.34M	12.28M	11.78M	11.52M	9.9M	9.28M	7.86M	6.73M	5.52M	4.8M	3.73M	2.88M
Shares Outstanding (Diluted)	18.29M	17.76M	16.87M	17.25M	16.18M	19.76M	24.07M	23.48M	20.83M	21.23M	21.43M	20.75M	19.85M	19.71M	19.61M	18.86M	15.92M	16.35M	13.44M	12.34M	12.28M	11.78M	11.52M	9.9M	9.28M	7.86M	6.73M	5.52M	4.8M	3.73M	2.88M
EPS (Basic)	-0.22	3.02	-0.31	3.44	-0.18	33.13	5.96	0.60	-0.08	13.00	0.59	0.56	-0.03	0.52	-0.64	-0.1	-6.16	17.22	-2.36	-2.95	-3.68	-3.18	-2.83	-4.34	-7.8	-9.51	-17.51	-18.15	-7.78	-17.19	-9.42
EPS (Diluted)	-0.22	2.94	-0.31	3.31	-0.18	31.85	5.96	0.53	-0.08	12.12	0.56	0.55	-0.03	0.52	-0.64	-0.1	-6.16	17.22	-2.36	-2.95	-3.68	-3.18	-2.83	-4.34	-7.8	-9.51	-17.51	-18.15	-7.78	-17.19	-9.42
EBITDA	40.79M	101.73M	54.41M	133.16M	69.05M	38.01M	238.3M	81.15M	55.17M	29.96M	23.37M	18.65M	3.94M	1.74M	-13.13M	-6.47M	-96.26M	-50.11M	-61.86M	-26.47M	-18.27M	-59.69M	-35.13M	-16.56M	-38.64M	-54.19M	-65.1M	-21M	-23.5M	-21.2M	-18.4M
EBIT	5.55M	64.32M	37.81M	91.82M	28.71M	-5.72M	221.61M	68.63M	20.8M	27.33M	20.71M	15.98M	1.22M	254K	-15.35M	-9.6M	-97.31M	-52.72M	-78.08M	-43.63M	-15.38M	-74.02M	-43.85M	-23.14M	-45.88M	-61.29M	-69.6M	-30.8M	-32.9M	-24.9M	-20.9M
Depreciation & Amortization	35.24M	37.41M	43.39M	41.34M	27.97M	43.73M	16.69M	12.52M	11.29M	2.63M	2.66M	2.66M	2.73M	2.79M	2.21M	3.13M	1.05M	2.62M	16.22M	18.71M	15.28M	14.28M	10.47M	6.57M	6.97M	7.4M	7.7M	9.8M	9.4M	3.7M	2.5M